3Branch DW, Andres R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol, 1989,73:541-545.
4Sibai BM, Mercer BM, Schiff E, et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol,1994,171:818-822.
5Hall DR, Odendaal HJ, Steyn DW, et al. Expectant management of early onest, severe pre-eclampsia: maternal outcome. BJOG ,2000,107:1252-1257.
6Cunningham FC, Gant NF, Leveno KJ, eds. Williams Obstetrics. 21st ed. New York: McGraw-Hill ,2001. 569-570.
7Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?Am J Obstet Gynecol, 1999,180:221-225.
8Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol,1998,179:1632-1639.
9Hall DR, Odendaal HJ, Kirsten GF, et al. Expectant management of early onest, severe pre-eclampsia: perinatal outcome. BJOG,2000,107:1258-1264.
10Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol, 1990, 76:1070-1075.
